← Back to Search

Device

On-Demand Oxygen Therapy for Patient Monitoring

N/A
Waitlist Available
Led By Kai Kuck, Ph.D.
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured continuously with every heart beat (i.e., approx. every 500-2000msec) throughout the surgical procedure
Awards & highlights

Study Summary

This trialis investigating if giving oxygen only when patients breathe in is more effective than constant flow. It will measure the difference in oxygen saturation and end-tidal oxygen levels and end-tidal CO2 when oxygen delivery is off during expiration.

Who is the study for?
This trial is for relatively healthy patients undergoing sedation and pain relief during procedures, who are classified as ASA class I-III. It's not suitable for those with oxygen saturation below 93% on room air, severe lung or heart conditions, pregnant women, very high-risk surgery patients (ASA class IV+), short procedures under 20 minutes, or individuals under 18.Check my eligibility
What is being tested?
The study tests if an 'on-demand' oxygen delivery system that provides oxygen only when a patient inhales is more effective than traditional continuous-flow systems. The effectiveness will be measured by blood oxygen levels and the accuracy of CO2 monitoring when the flow is stopped during exhalation.See study design
What are the potential side effects?
While specific side effects aren't listed for this type of device trial, potential risks may include discomfort from wearing the device or inaccuracies in oxygen/CO2 level readings which could affect patient safety.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured continuously with every heart beat (i.e., approx. every 500-2000msec) throughout the surgical procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured continuously with every heart beat (i.e., approx. every 500-2000msec) throughout the surgical procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
End-tidal Carbon Dioxide
End-tidal Oxygen
Oxygen Saturation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Only ArmExperimental Treatment3 Interventions
Two minutes: Intervention: Device: On Demand Oxygen Delivery 20 sec or 3 breaths, whatever comes first: Intervention: Device: Oxygen Flow Stopped Two minutes intervention: Device: Traditional, Always-On, Oxygen Delivery 20 sec or 3 breaths, whatever comes first: Intervention: Device: Oxygen Flow Stopped Repeat until the end of the surgical procedure

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,098 Previous Clinical Trials
1,778,530 Total Patients Enrolled
Kai Kuck, Ph.D.Principal InvestigatorUniversity of Utah Department of Anesthesiology
2 Previous Clinical Trials
49 Total Patients Enrolled

Media Library

On Demand Oxygen Delivery System (Device) Clinical Trial Eligibility Overview. Trial Name: NCT02962570 — N/A
Oxygen Delivery Research Study Groups: Only Arm
Oxygen Delivery Clinical Trial 2023: On Demand Oxygen Delivery System Highlights & Side Effects. Trial Name: NCT02962570 — N/A
On Demand Oxygen Delivery System (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02962570 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there available slots for enrolment in this scientific experiment?

"As indicated by clinicaltrials.gov, this investigation is no longer recruiting participants as it was last updated on October 31st 2022. However, there are two other trials that remain open for enrollment currently."

Answered by AI
~6 spots leftby Nov 2024